Cart
sales@molnova.com
KBP-7018 hydrochloride
CAS No. 1613437-67-4
KBP-7018 hydrochloride( KBP 7018 hydrochloride | KBP7018 hydrochloride )
Catalog No. M12342 CAS No. 1613437-67-4
A novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 963 | Get Quote |
|
| 50MG | 1962 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKBP-7018 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
-
DescriptionA novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively; also potently inhibits FLT3, VEGFR2, Fyn, PDGFRα and VEGFR2; shows promising outcomes for the treatments of idiopathic pulmonary fibrosis (IPF).
-
In Vitro——
-
In Vivo——
-
SynonymsKBP 7018 hydrochloride | KBP7018 hydrochloride
-
PathwayAngiogenesis
-
Targetc-Kit
-
Recptorc-Kit
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1613437-67-4
-
Formula Weight575.06
-
Molecular FormulaC31H31ClN4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC(=O)C1=CC2=C(C=C1)C(=C(N2)O)C(=NC3=CC4=C(C=C3)N(CC4)C(=O)CN5CCOCC5)C6=CC=CC=C6.Cl
-
Chemical NameMethyl (Z)-3-(((1-(2-morpholinoacetyl)indolin-5-yl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang Z, et al. ACS Med Chem Lett. 2017 Sep 30;8(11):1142-1147.
2. Huang Z, et al. Drug Des Devel Ther. 2015 Aug 5;9:4319-28.
molnova catalog
related products
-
ISCK03
A specific c-Kit inhibitor that inhibits c-kit phosphorylation in vitro and SCF-induced c-kit phosphorylation in human melanoma cells.
-
Sitravatinib
A novel, broad spectrum small molecule inhibitor that blocks a wide array of RTKs known to be amplified/overexpressed in sarcomas, including c-Kit, PDGFRβ, PDGFRα, c-Met, and Axl (IC50=1.5-30 nM).
-
CS-2660
CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
